There is nothing wild, or any conspiracy about it. After all we are dealing with a small biotech equity and there is that risk involved (this has been discussed many times on the board). Part of investing and learning.
Experienced biotech investors know that it does not take much for a company with 4.7B MC to be cut to size. You may want to confirm this with Investor or Doc.
Market Data 
Markets 
